| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_cfecc5feb45f49de812ee7a2850af8d4
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_9051cdae59d32aa5ab588a63df61b3da |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D513-06
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D215-56 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D513-06
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D215-56 |
| filingDate |
1994-10-26-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_ff289368da7a2facd337a1072d7eef7c |
| publicationDate |
1995-05-04-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
WO-9511907-A1 |
| titleOfInvention |
Process for the preparation of rufloxacin and salts thereof |
| abstract |
Rufloxacin is prepared by reducing a quinolon disulfide of formula (II) subjecting the 2-mercaptoethyl quinolone thus obtained of formula (III) to a cyclization in a basic medium and hydrolyzing the rufloxacin ester thus obtained to isolate rufloxacin. A new method for hydrolyzing rufloxacin ester to rufloxacin and its pharmaceutically acceptable salts is also described. |
| isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-10945958-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-10959954-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11612567-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11279729-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-10588862-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-10632075-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-2939695-A1 |
| priorityDate |
1993-10-27-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |